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Introduction {#vde12269-sec-0067}
============

Contagious ovine digital dermatitis (CODD) is a cause of infectious lameness in sheep in the UK and Ireland and has been shown to have a severe impact on the welfare of affected individuals.[1](#vde12269-bib-0001){ref-type="ref"} Recent surveys have shown that CODD may affect approximately 35% of flocks in the UK; while on‐farm prevalence is typically low, it may affect up to 50% of the flock at any one time.[1](#vde12269-bib-0001){ref-type="ref"}

Information about the microbial flora of CODD lesions is limited, although the bovine digital dermatitis (BDD) associated treponemes *Treponema medium/T. vincentii*‐like, *Treponema phagedenis*‐like and *Treponema pedis* are currently considered to be a necessary cause of disease.[1](#vde12269-bib-0001){ref-type="ref"} The recent characterization of treponemes associated with CODD demonstrated the presence of at least one BDD phylotype present in all 58 lesions studied, whereas these were totally absent from all healthy sheep foot tissues.[2](#vde12269-bib-0002){ref-type="ref"}

There has been a wide range of empirically chosen treatments employed in clinical cases such as parenteral oxytetracycline and topical tylosin,[3](#vde12269-bib-0003){ref-type="ref"} with only one randomized controlled trial conducted comparing parenteral amoxicillin and simultaneous topical chlortetracycline with topical chlortetracycline alone.[4](#vde12269-bib-0004){ref-type="ref"}

As with CODD, the successful treatment of BDD has remained problematic with many farms adopting management and control strategies as opposed to affecting a cure.[5](#vde12269-bib-0005){ref-type="ref"} In order to inform the development of effective therapeutic strategies for clinical cases of CODD, a greater understanding is required of the susceptibility of the treponemes found in CODD lesions to antimicrobials currently available for use in sheep.

The aim of this study was to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of a panel of antimicrobials for representatives from each of the three treponeme phylogroups cultured as pure isolates from clinical CODD lesions.

Materials and methods {#vde12269-sec-0068}
=====================

Bacterial isolates {#vde12269-sec-0069}
------------------

Twenty treponeme isolates from CODD lesions from 19 sheep from six farms in England, Wales and Northern Ireland were used (Table [1](#vde12269-tbl-0001){ref-type="table-wrap"}). Included were five isolates from the *T. medium/T. vincentii*‐like group, 10 isolates from the *T. phagedenis*‐like group and five isolates from the *T. pedis* group.

###### 

Treponemes tested for susceptibility to antimicrobial agents

  Strain no.   Strain         Isolation date   UK Location        Nearest related organism[a](#vde12269-note-0004){ref-type="fn"}
  ------------ -------------- ---------------- ------------------ -----------------------------------------------------------------
  1            G1F7C5         07/2013          Conwy              *Treponema medium/Treponema vincentii*
  2            G1F9C27        07/2013          Conwy              *Treponema medium/Treponema vincentii*
  3            G1OV11         08/2009          Gloucester         *Treponema medium/Treponema vincentii*
  4            G2S2R          02/2009          Cheshire           *Treponema medium/Treponema vincentii*
  5            ST27           07/2013          Conwy              *Treponema medium/Treponema vincentii*
  6            3F2            02/2014          Anglesey           *Treponema phagedenis*
  7            C2F            06/2009          Gloucestershire    *Treponema phagedenis*
  8            G2S4F          02/2009          Cheshire           *Treponema phagedenis*
  9            G2F3C12        07/2013          Conwy              *Treponema phagedenis*
  10           G13F3          02/2014          Denbighshire       *Treponema phagedenis*
  11           G2SL1          05/2014          Anglesey           *Treponema phagedenis*
  12           G23F1          02/2014          Anglesey           *Treponema phagedenis*
  13           S3R2           03/2009          Cheshire           *Treponema phagedenis*
  14           G2ST24         07/2013          Conwy              *Treponema phagedenis*
  15           C2R            06/2009          Gloucestershire    *Treponema phagedenis*
  16           Ovine (G179)   2000             Northern Ireland   *Treponema pedis*
  17           G3ST1          07/2014          Shrewsbury         *Treponema pedis*
  18           G3S45          07/2014          Shrewsbury         *Treponema pedis*
  19           G3T1           07/2014          Shrewsbury         *Treponema pedis*
  20           G3T7           07/2014          Shrewsbury         *Treponema pedis*

As determined by 16S rRNA gene phylogenetic analysis.
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*In vitro* antimicrobial susceptibility testing {#vde12269-sec-0070}
-----------------------------------------------

The MIC/MBC for each antimicrobial was determined using a broth microdilution method as previously described.[6](#vde12269-bib-0006){ref-type="ref"} One small adjustment was made to the method such that prior to inoculation, bacterial counts were assessed by determining the optical density (OD) of the cultures using spectrometry with wavelength set at 540 nm. The *T. medium/T. vincentii*‐like cultures had an OD of 0.25; the *T. phagedenis*‐like cultures had an OD of 0.43 and the *T. pedis* cultures had an OD of 0.37. This corresponds to 8.75 × 10^7^, 1.14 × 10^8^ and 2.69 × 10^8^ treponemal organisms/mL, respectively.[6](#vde12269-bib-0006){ref-type="ref"} At this time point, cultures were assessed by phase contrast microscopy to determine that the cultures were alive, of the correct morphology and lacking contaminants. The antimicrobials and their test ranges are listed in Table [2](#vde12269-tbl-0002){ref-type="table-wrap"}.

###### 

Minimum inhibitory concentrations (MIC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes

  Strain no.[a](#vde12269-note-0005){ref-type="fn"}   Median MIC (mg/L)                                                                  
  --------------------------------------------------- ------------------- -------- ------- -------- ---- ---- -------- -------- -------- --------
  1                                                   0.0750              0.5625   3       0.0703   24   12   0.0234   0.2930   0.0469   0.0469
  2                                                   0.0375              0.2813   3       0.0234   48   24   0.0234   0.2930   0.0234   0.0234
  3                                                   0.0375              0.5625   1.5     0.0117   48   12   0.0469   1.1719   0.0469   0.0234
  4                                                   0.0750              0.2813   1.5     0.0234   24   12   0.0469   0.2930   0.0234   0.0469
  5                                                   0.0750              0.5625   3       0.0117   24   24   0.0469   1.1719   0.0469   0.0469
  6                                                   0.0375              0.1406   0.75    0.0234   24   12   0.0469   0.5859   0.0469   0.0469
  7                                                   0.0188              0.1406   0.75    0.0469   12   12   0.0938   0.5859   0.0117   0.0469
  8                                                   0.0750              0.2813   0.375   0.0094   12   12   0.0469   0.2930   0.0117   0.0469
  9                                                   0.0375              0.1406   0.75    0.1875   24   12   0.0469   0.5859   0.0234   0.1875
  10                                                  0.0188              0.1406   0.75    0.0234   6    12   0.0117   0.5859   0.0469   0.0469
  11                                                  0.0188              0.2813   0.75    0.0234   3    6    0.0938   0.1465   0.0117   0.0469
  12                                                  0.0750              0.1181   0.375   0.0059   6    3    0.0469   0.2930   0.0029   0.0059
  13                                                  0.0375              0.1181   0.375   0.375    12   12   0.0234   0.5859   0.0938   0.1875
  14                                                  0.0750              0.1181   0.375   0.0938   48   12   0.0234   0.5859   0.0938   0.0234
  15                                                  0.0188              0.1406   1.5     0.1875   96   24   0.0469   0.2930   0.0234   0.0938
  16                                                  0.0750              0.2813   1.5     0.0234   24   24   0.0234   0.5859   0.0234   0.0938
  17                                                  0.0375              0.5625   6       0.0234   48   24   0.0234   0.5859   0.0469   0.0469
  18                                                  0.0750              0.5625   3       0.0234   48   12   0.0469   0.5859   0.0234   0.0469
  19                                                  0.0750              0.2813   1.5     0.0117   48   24   0.0469   0.5859   0.0234   0.0938
  20                                                  0.0750              0.5625   6       0.0117   96   24   0.0234   1.1719   0.0234   0.0938
  MIC~90~ [b](#vde12269-note-0007){ref-type="fn"}     0.0750              0.5625   3       0.1875   48   24   0.0469   1.1719   0.0469   0.0938

Isolates 1--5 are *Treponema medium/Treponema vincentii*‐like BDD spirochaetes with antibiotic test ranges (μg/L) of: penicillin G 0.75--0.0059; amoxicillin 2.25--0.0176; oxytetracycline 12--0.0938; tilmicosin 0.375--0.0029; lincomycin 192--1.5; spectinomycin 48--0.375 (Sigma‐Aldrich; Dorset, UK); tildipirosin 0.75--0.0059 (Zuprevo, MSD Animal Health; Milton Keynes, UK); tulathromycin 9.375--0.0732 (Draxxin, Zoetis UK Limited; London, UK); gamithromycin 0.188--0.0015 (Merial LLC; Duluth, Georgia, USA); and tylosin 0.375--0.0029 (Sigma‐Aldrich).

Isolates 6--15 are *Treponema phagedenis*‐like CODD spirochaetes and isolates 16--20 are *Treponema pedis* CODD spirochaetes with test ranges the same as those for *Treponema medium/Treponema vincentii*‐like BDD spirochaetes.

Cumulative susceptibility results across all treponemes tested are expressed as MIC90, the concentration at which 90% of CODD‐associated treponemes were inhibited.
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Determination of MICs {#vde12269-sec-0071}
---------------------

The MIC for each antimicrobial was taken as the lowest concentration of antimicrobial that prevented growth in the wells observed at the same time points.[6](#vde12269-bib-0006){ref-type="ref"} Cell growth was determined by comparison of the absorbance measurement immediately after inoculation with the absorbance measured at the late exponential/early stationary phase. All of the absorbance measurements were at 540 nm using a Multiskan microtitre plate reader (Thermo Scientific; Hampshire, UK). The MIC values were taken as the median of three repeat experiments, performed on different days.

Determination of MBCs {#vde12269-sec-0072}
---------------------

The MBC for each antimicrobial was determined as previously described.[6](#vde12269-bib-0006){ref-type="ref"}

Determination of MIC~90~ and MBC~90~ {#vde12269-sec-0073}
------------------------------------

The cumulative inhibitory/bactericidal concentration for each antimicrobial tested across all the treponeme isolates was expressed as the concentration at which 90% of CODD‐associated treponemes were inhibited from growing (MIC90) or killed (MBC90).

Statistical analysis {#vde12269-sec-0074}
--------------------

Differences in MICs between the three different treponeme phylogroups were assessed using the Kruskal--Wallis test. The Kruskal--Wallis test and the nonparametric equality‐of‐medians test were used to compare the MICs for penicillin, oxytetracycline, lincomycin and spectinomycin with previous data,[6](#vde12269-bib-0006){ref-type="ref"} and for amoxicillin and gamithromycin.[7](#vde12269-bib-0007){ref-type="ref"} All statistical analyses were conducted using Stata IC 13 (Stata Corp; College Station, TX, USA) and statistical significance was set at *P *\<* *0.05.

Study validation {#vde12269-sec-0075}
----------------

The MIC microdilution method described in this study was validated by comparing the results produced from four antimicrobials (penicillin, oxytetracycline, lincomycin and erythromycin) incubated with two control microorganisms *T. phagedenis* biotype Reiter and *T. phagedenis*‐like T320A against results previously obtained using a macrodilution method[8](#vde12269-bib-0008){ref-type="ref"} and also results obtained using a similar microdilution method.[6](#vde12269-bib-0006){ref-type="ref"}, [7](#vde12269-bib-0007){ref-type="ref"} The data were also compared statistically using linear regression.

Results {#vde12269-sec-0076}
=======

Antimicrobial susceptibilities of CODD‐associated treponemes {#vde12269-sec-0077}
------------------------------------------------------------

The individual MIC/MBCs of the antimicrobial agents to each treponeme isolate are summarized in Tables [2](#vde12269-tbl-0002){ref-type="table-wrap"} and [3](#vde12269-tbl-0003){ref-type="table-wrap"}; in this study all isolates showed low MIC/MBCs to all of the antimicrobials tested. Using Table [2](#vde12269-tbl-0002){ref-type="table-wrap"}, all treponeme groups were most susceptible to gamithromycin and tildipirosin, and least susceptible to lincomycin, spectinomycin and oxytetracycline. The MIC90 for the other five antimicrobials were all relatively low, being \<1.0 μg/mL. No bimodal distributions were identified.

###### 

Minimum bactericidal concentrations (MBC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes

  Strain no.[a](#vde12269-note-0008){ref-type="fn"}   Median MBC (mg/L)                                                                  
  --------------------------------------------------- ------------------- -------- ------- -------- ---- ---- -------- -------- -------- --------
  1                                                   0.0750              0.5625   6       0.0938   48   12   0.0469   0.5859   0.0469   0.0938
  2                                                   0.0750              0.5625   3       0.0469   96   24   0.0469   0.2930   0.0469   0.0938
  3                                                   0.0750              1.1250   3       0.0234   48   24   0.0469   1.1719   0.0469   0.0938
  4                                                   0.0750              0.5625   3       0.0469   48   24   0.0469   0.5859   0.0234   0.0938
  5                                                   0.0750              0.5625   6       0.0234   24   24   0.0469   1.1719   0.0469   0.0938
  6                                                   0.0375              0.5625   6       0.0469   48   12   0.0938   0.5859   0.0469   0.3750
  7                                                   0.0375              0.5625   3       0.1875   24   24   0.0938   0.5859   0.0234   0.0938
  8                                                   0.0750              0.5625   3       0.1875   24   12   0.0469   1.1719   0.0234   0.3750
  9                                                   0.0750              0.5625   6       0.1875   96   24   0.0938   0.1172   0.0469   0.1875
  10                                                  0.0375              0.2813   6       0.0234   96   12   0.0234   0.5859   0.0469   0.0469
  11                                                  0.0189              0.2813   3       0.0234   48   6    0.3750   0.5859   0.0117   0.0469
  12                                                  0.0750              0.2813   1.5     0.0117   24   6    0.0469   0.5859   0.0117   0.0117
  13                                                  0.0375              0.1181   0.75    0.1875   24   12   0.0234   1.1719   0.0938   0.1875
  14                                                  0.0750              0.5625   0.375   0.0938   48   12   0.0234   0.5859   0.0938   0.0938
  15                                                  0.0188              0.2813   0.75    0.1875   24   12   0.0469   0.5859   0.0234   0.0938
  16                                                  0.0750              0.5625   3       0.0234   48   24   0.0469   0.5859   0.0469   0.0938
  17                                                  0.0750              0.5625   6       0.0234   96   24   0.0469   0.5859   0.0469   0.0938
  18                                                  0.0750              0.5625   6       0.0469   48   12   0.0469   1.1719   0.0234   0.0938
  19                                                  0.0750              0.5625   6       0.0469   48   24   0.0469   1.1719   0.0469   0.0938
  20                                                  0.0750              0.5625   6       0.0234   96   24   0.0234   1.1719   0.0469   0.0938
  MBC~90~ [b](#vde12269-note-0009){ref-type="fn"}     0.0750              0.5625   6       0.1875   96   24   0.0938   1.1719   0.0469   0.1875

1--5, *Treponema medium/Treponema vincentii*‐like; 6--15, *Treponema phagedenis*‐like; 16--20, *Treponema pedis*.

Cumulative susceptibility results across all treponemes tested are expressed as MBC90, the concentration at which 90% of CODD‐associated treponemes were killed.
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Variation in MIC across the different treponeme phylogroups {#vde12269-sec-0078}
-----------------------------------------------------------

There was no significant difference in MIC values between the three different phylogroups for five of the seven macrolides (*P* = 0.2), with phylogroup differences for lincomycin and spectinomycin approaching significance (*P* = 0.05). Whilst there was no significant difference between phylogroups in the case of penicillin MIC (*P* = 0.1), in the case of amoxicillin and oxytetracycline, *T. phagedenis*‐like bacteria were more susceptible compared to *T. medium/T. vincentii*‐like and *T. pedis* (*P* = 0.002 and *P* = 0.001, respectively).

Comparisons with data from previous studies {#vde12269-sec-0079}
-------------------------------------------

The MICs for penicillin, oxytetracycline, lincomycin, spectinomycin, amoxicillin and gamithromycin for the 20 isolates investigated here, were not significantly different to those previously reported.[6](#vde12269-bib-0006){ref-type="ref"}, [7](#vde12269-bib-0007){ref-type="ref"}

Study validation {#vde12269-sec-0080}
----------------

The comparison described matched the previous results in all cases except for one antimicrobial (oxytetracycline), which was different by one serial dilution when compared with the macrodilution method.[8](#vde12269-bib-0008){ref-type="ref"} Linear regression for these comparisons showed strong correlations (*R* = 0.99 *P* \< 0.004) indicating the efficacy and reproducibility of this microdilution method.

Discussion {#vde12269-sec-0081}
==========

Study validation and comparisons with data from previous studies {#vde12269-sec-0082}
----------------------------------------------------------------

The methodological validations described reinforce the comparable nature of these current data with previous studies. Comparisons of these current data for penicillin, oxytetracycline, lincomycin and spectinomycin with previous studies do not reveal any statistically significant differences.[6](#vde12269-bib-0006){ref-type="ref"}, [7](#vde12269-bib-0007){ref-type="ref"} Therefore, these current data make a valuable contribution to the available data on the *in vitro* antimicrobial susceptibility of these treponemes.

Antimicrobial use in sheep with CODD {#vde12269-sec-0083}
------------------------------------

All of the isolates in this study were susceptible (*in vitro*) to all the antimicrobials tested, with gamithromycin, tildipirosin, penicillin, tylosin and tilmicosin demonstrating the lowest MICs and MBCs. This susceptibility, however, may not necessarily be reflected *in vivo*. To date, there have been very few robust *in vivo* studies examining effective treatment. In two clinical studies[4](#vde12269-bib-0004){ref-type="ref"}, [9](#vde12269-bib-0009){ref-type="ref"} systemic amoxicillin together with topical chlortetracycline was found to have a clinical cure rate in clinical cases of CODD of approximately 80%. Anecdotally, systemic tilmicosin was also proposed to be an effective treatment for sheep with CODD[10](#vde12269-bib-0010){ref-type="ref"} and systemic oxytetracycline together with a tylosin footbath were considered to be an effective preventative method.[3](#vde12269-bib-0003){ref-type="ref"}

Currently, no antimicrobial product has a license for CODD in the UK. The antimicrobials studied here were selected to include antimicrobials that already have a license for sheep (penicillin, amoxicillin, oxytetracycline and tilmicosin) together with those that in the authors' experience are already used (off label) in the sheep industry. Therefore, given this context and these data as a whole, penicillin and tilmicosin would appear to be the most likely candidates for future *in vivo* studies.

This study provides the first detailed examination of the *in vitro* antimicrobial susceptibilities of all three associated phylogroups of treponemes cultured from CODD lesions to antimicrobials. As such, these data provide important *in vitro* information on antimicrobials currently used to treat this disease and should help inform researchers planning further *in vivo* studies when considering which products to include.

The authors are grateful to all of the farmers who provided their sheep for this study.

[^1]: The first two authors contributed equally to this manuscript.
